RecruitingNot ApplicableNCT06468293

Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer

The Role of Caregiver in the Clinical Pathway of Patients Newly Diagnosed With Breast and Prostate Cancer: a Randomized Study


Sponsor

European Institute of Oncology

Enrollment

102 participants

Start Date

Oct 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The following randomized longitudinal study will evaluate the long term impact of caregivers' involvement in cancer care pathway, including a psychological support intervention on the dyads to be delivered after the detection of a suspected cancer and before the visit with the oncologist for discussing therapeutic options.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Patient:
  • Patient aged ≥18 years at the time of recruitment.
  • Patients who have just received a cancer diagnosis and have yet to discuss with their oncologist the treatment to undergo after diagnosis of breast or prostate cancer.
  • Early-stage cancer (I or II).
  • Caregiver:
  • Age ≥ 18 at the time of recruitment.
  • Taking care of the patient.

Exclusion Criteria5

  • Patients:
  • Presence of early mental disorders (before age 40) or severe neurological disorder.
  • Patients with advanced stage cancer for which the path is already defined (palliative care patients).
  • Caregivers:
  • ● Presence of early mental disorders (before age 40) or severe neurological disorder.

Interventions

OTHERPsychological support

Psychological support intervention


Locations(1)

European Institute of Oncology

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06468293


Related Trials